The MarketWatch News Department was not involved in the creation of this content.-- Rezurock(R) (belumosudil tablets) now listed for public reimbursement, offering access to adult ...

Sanofi is pleased to announce that Quebec has added Rezurock® (belumosudil tablets) to the list of medications covered by the ...

Introduction: The occurrence of monoclonal gammopathies (MG) and oligoclonal (two or more monoclonal proteins) gammopathies (OG) might be triggered by some factors, such as immune recovery following ...

In a landmark advancement for Indian healthcare, doctors at FMRI, Gurugram, have reported exceptional success in curing children suffering from Sickle Cell Disease (SCD) through Bone Marrow (stem cell ...

MaaT Pharma Announces Positive Phase 3 Results Evaluating Xervyteg® (MaaT013) in aGvHD Selected for Oral Presentation at ASH ...

Incyte has expanded its support for projects tackling unmet needs to cover hidradenitis suppurativa (HS) patients, tightening ...

ReAlta Life Sciences, Inc. ("ReAlta" or the "Company"), a clinical-stage biopharmaceutical company dedicated to saving lives ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

The treatment of relapsed/refractory multiple myeloma dramatically changed in recent years with the emergence of therapies ...

Nagpur, achieved a major healthcare milestone with the inauguration of three key patient care facilities — the assisted ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...

Cynata Therapeutics Limited ( OTCPK:CYYNF) Discusses Clinical Trial Progress and Corporate Developments Including GVHD, Osteoarthritis, and Kidney Transplantation November 5, 2025 8:30 PM EST ...